GPB Capital has named Dotty Bollinger, who has more than 30 years of experience in the healthcare industry, as Managing Partner in charge of its new Healthcare Strategy.
GPB Capital focuses on acquiring mature, income-producing companies in necessity-based sectors, including retail automotive, waste management, and managed IT, and now, healthcare.
“Dotty has an impressive track record of working closely with healthcare companies to achieve the next level of growth and profitability, while delivering medical innovations directly to patients and driving outstanding financial results to investors,” says David Gentile, Founder and CEO of GPB Capital. “Dotty’s broad expertise and experience will assist us greatly as we look to partner with management teams at established healthcare companies across the country.”
Bollinger will play a pivotal role in helping GPB Capital formulate its Healthcare Strategy through sourcing, structuring, finalising, and monitoring acquisitions of healthcare companies that focus on women’s health, physical therapy, and other fields. Before she joined GPB Capital, Bollinger served as CEO of Integrity Healthcare Advisors, a national consulting firm that works with healthcare practice owners across the country to improve patient satisfaction, employee engagement, and profitability.
Prior to Integrity Healthcare Advisors, Bollinger served as President and Chief Operating Officer of Laser Spine Institute, where she established and led the team that helped the firm achieve the national footprint it enjoys today through scalable growth. She also oversaw all corporate and medical operations at the Laser Spine Institute, as well as the recruitment of surgeons and key executive staff.
“The team at GPB Capital cares deeply about the organisations it partners with, their teammates, and ultimately, their consumers,” says Bollinger. “Joining GPB Capital offers an opportunity to make a difference by empowering healthcare companies to expand their market share, and bring innovative technologies and procedures to patients around the US who need them.”